id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1196287,d82ba2eb-0a4e-4f08-bdae-a7e34dc8565f,Q4,THE DUBERSTEIN GROUP INC.,12675,PFIZER INC.,2011,fourth_quarter,HCR,"National Institute of Health funding for Alzheimer's disease - HR 2055, Consolidated Appropriations Act, 2012.","HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)",100000,,0,0,2012-01-19T14:20:47-05:00
1196288,d82ba2eb-0a4e-4f08-bdae-a7e34dc8565f,Q4,THE DUBERSTEIN GROUP INC.,12675,PFIZER INC.,2011,fourth_quarter,TRD,"US-Korea Free Trade Agreement - HR 3080, United States-Korea Free Trade Agreement Implementation Act (PL 112-41).","HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)",100000,,0,0,2012-01-19T14:20:47-05:00
1196289,d82ba2eb-0a4e-4f08-bdae-a7e34dc8565f,Q4,THE DUBERSTEIN GROUP INC.,12675,PFIZER INC.,2011,fourth_quarter,TAX,"Corporate tax reform, including international taxes and tax extenders - Proposed legislation re these issues.","HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)",100000,,0,0,2012-01-19T14:20:47-05:00
1196290,d82ba2eb-0a4e-4f08-bdae-a7e34dc8565f,Q4,THE DUBERSTEIN GROUP INC.,12675,PFIZER INC.,2011,fourth_quarter,MMM,"Impact of deficit reduction issues, and actions of the Joint Committee on Deficit Reduction on Medicare, Medicare Part B, and Medicare Part D - Proposed legislation re these issues.
Sustainable growth rate and impact on other Medicare programs - HR 3630, Temporary Payroll Tax Cut Continuation Act of 2011; HR 3765, Temporary Payroll Tax Cut Continuation Act of 2011.","HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)",100000,,0,0,2012-01-19T14:20:47-05:00
1196291,d82ba2eb-0a4e-4f08-bdae-a7e34dc8565f,Q4,THE DUBERSTEIN GROUP INC.,12675,PFIZER INC.,2011,fourth_quarter,PHA,"Reimported drugs from Canada - HR 2112, Consolidated and Further Continuing Appropriations Act, 2012.
Counterfeit drug penalty enforcement act - S 1886, Counterfeit Drug Penalty Enhancement Act of 2011.
Patent and generic drugs - Congressional investigation re this issue.","HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)",100000,,0,0,2012-01-19T14:20:47-05:00